LOOMIS SAYLES & CO L P

Position in LGND — Ligand Pharmaceuticals Inc

CIK 312348 BOSTON, MA

Position in LGND

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$70,518,176

-$1,834,563 QoQ

Shares Held

353,209

-7.7% QoQ

Ownership

1.76%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 98.17615066433754.ToString("F0")% Shared 0.ToString("F0")% None 1.8238493356624548.ToString("F0")%

Healthcare · as of Mar 31, 2026

LOOMIS SAYLES & CO L P holds $4,075,180,510 across 25 Biotechnology names. LGND ranks #4 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	4,003,821	$1,787,866,229
2	REGN	Regeneron Pharmaceuticals, Inc.	1,912,310	$1,477,527,197
3	ALNY	Alnylam Pharmaceuticals, Inc.	512,097	$169,437,533
4	LGND	Ligand Pharmaceuticals Inc This page	353,209	$70,518,176
5	CRSP	CRISPR Therapeutics AG	968,135	$46,054,181
6	MIRM	Mirum Pharmaceuticals, Inc.	475,324	$43,910,430
7	AXSM	Axsome Therapeutics, Inc.	256,625	$43,374,756
8	RYTM	Rhythm Pharmaceuticals, Inc.	465,102	$40,449,920

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$70,518,176	353,209	-7.7%	Shares	Defined	2026-05-14
2025-12-31	$72,352,739	382,677	-4.5%	Shares	Defined	2026-02-12
2025-09-30	$70,953,958	400,553	-2.5%	Shares	Defined	2025-11-13
2025-06-30	$46,710,770	410,897	-2.4%	Shares	Defined	2025-08-13
2025-03-31	$44,246,486	420,834	+5.8%	Shares	Defined	2025-05-14
2024-12-31	$42,613,554	397,700	+6.7%	Shares	Defined	2025-02-12
2024-09-30	$37,311,449	372,779	+44.3%	Shares	Defined	2024-11-13
2024-06-30	$21,767,980	258,343	—	Shares	Defined	2024-08-13
No filing history on record for this holder in this stock.